NRAS and melanoma: This custom ddPCR panel would have a predicted coverage of ~80% of cutaneous melanomas based on the skin cutaneous melanoma TCGA dataset which gives a BRAF/NRAS coverage of ~70% [27,28] and the fact that TERT promoter mutations are found in around ~29% of BRAF wild-type melanoma patients [39].